Trade PLRX stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Pliant Therapeutics, Inc. (PLRX) is trading at US$0.99, up 0.10% today as of Oct 8, 12:51 EDT. The company has a market capitalisation of US$71.52M. Over the past 52 weeks, PLRX has traded between US$0.97 and US$1.95. On Syfe you can trade PLRX with $0 commission and add it to your watchlist.
| Previous close | US$0.99 |
|---|---|
| Market cap | US$71.52M |
| 52-week range | US$0.97 – US$1.95 |
| Volume | 756.5K |
| Exchange | US |
Pliant Therapeutics, Inc.
Pliant Therapeutics, Inc. engages in the discovery, development and commercialization of therapies for fibrotic diseases. It offers a product discovery engine. The company is pursuing drug development programs for a range of fibrotic diseases, focusing on tissue-specific integrin modulation and TGF-ß1 signaling inhibition. The company was founded by Bradley Backes, Bill De Grado, Hal Chapman, and Dean Sheppard in June 2015 and is headquartered in South San Francisco, CA.
Year: 2020
Pliant Therapeutics, Inc. (PLRX) stock is trading at US$0.99, +0.10% from the previous close of US$0.99.
The market cap for Pliant Therapeutics, Inc. (PLRX) stock is approximately US$71.52M.
The 52-week high for Pliant Therapeutics, Inc. (PLRX) stock is US$1.95.
The 52-week low for Pliant Therapeutics, Inc. (PLRX) stock is US$0.97.
Pliant Therapeutics, Inc. (PLRX) does not currently pay a dividend.
Stay on top of PLRX
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore
